UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Nature (London), 2018-12, Vol.564 (7735), p.273-277

2018

Volltextzugriff (PDF)

G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma

Nature communications, 2019-02, Vol.10 (1), p.943-943, Article 943

2019

Volltextzugriff (PDF)

Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.529-538

2018

Volltextzugriff (PDF)

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists

Cancer cell, 2013-01, Vol.23 (1), p.23-34

2013

Volltextzugriff (PDF)

Targeting the AKT pathway in glioblastoma

Current pharmaceutical design, 2011-08, Vol.17 (23), p.2411-2420

2011

Volltextzugriff (PDF)

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer

Molecular cancer research, 2020-04, Vol.18 (4), p.517-528

2020

Volltextzugriff (PDF)

Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine

Oncotarget, 2013-10, Vol.4 (10), p.1729-1736

2013

Volltextzugriff (PDF)

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer

Endocrine-related cancer, 2020-03, Vol.27 (3), p.123-136

2020

Volltextzugriff (PDF)

Molecular targeting of glioblastoma: Drug discovery and therapies

Trends in molecular medicine, 2011-06, Vol.17 (6), p.301-312

2011

Volltextzugriff (PDF)

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

Neuro-oncology (Charlottesville, Va.), 2011-09, Vol.13 (9), p.974-982

2011

Volltextzugriff (PDF)

Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model

Clinical cancer research, 2015-08, Vol.21 (15), p.3462-3470

2015

Volltextzugriff (PDF)

Repurposing the antihelmintic mebendazole as a hedgehog inhibitor

Molecular cancer therapeutics, 2015-01, Vol.14 (1), p.3-13

2015

Volltextzugriff (PDF)

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

Nature communications, 2018-03, Vol.9 (1), p.1057-15, Article 1057

2018

Volltextzugriff (PDF)

Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness

Breast cancer research : BCR, 2022-12, Vol.24 (1), p.98-18, Article 98

2022

Volltextzugriff (PDF)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines

PloS one, 2016-03, Vol.11 (3), p.e0150271-e0150271

2016

Volltextzugriff (PDF)

Genes Expressed in Human Tumor Endothelium

Science (American Association for the Advancement of Science), 2000-08, Vol.289 (5482), p.1197-1202

2000

Volltextzugriff (PDF)

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

Journal of hepato-biliary-pancreatic sciences, 2014-06, Vol.21 (6), p.388-396

2014

Volltextzugriff (PDF)

Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells

Cancers, 2023-02, Vol.15 (4), p.1330

2023

Volltextzugriff (PDF)

Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

Nature communications, 2022-01, Vol.13 (1), p.190-190, Article 190

2022

Volltextzugriff (PDF)

Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers

Cancer immunology research, 2014-04, Vol.2 (4), p.371-379

2014

Volltextzugriff (PDF)

OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5988-6001

2012

Volltextzugriff (PDF)

Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy

PloS one, 2012-10, Vol.7 (10), p.e44372

2012

Volltextzugriff (PDF)

Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells

Molecular cancer therapeutics, 2009-02, Vol.8 (2), p.386-393

2009

Volltextzugriff (PDF)

Exomic sequencing of four rare central nervous system tumor types

Oncotarget, 2013-04, Vol.4 (4), p.572-583

2013

Volltextzugriff (PDF)

Yes-associated protein 1 is activated and functions as an oncogene in meningiomas

Molecular cancer research, 2012-07, Vol.10 (7), p.904-913

2012

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(171)

Publikationsform

Artikel
(183)
Buchkapitel
(1)

Sprache

Englisch
(183)
Japanisch
(45)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma

Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma

Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists

Targeting the AKT pathway in glioblastoma

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer

Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer

Molecular targeting of glioblastoma: Drug discovery and therapies

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model

Repurposing the antihelmintic mebendazole as a hedgehog inhibitor

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines

Genes Expressed in Human Tumor Endothelium

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells

Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers

OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells

Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy

Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells

Exomic sequencing of four rare central nervous system tumor types

Yes-associated protein 1 is activated and functions as an oncogene in meningiomas

Suchergebnisse filtern